aDuke Cancer Institute, Durham, North Carolina.
bNational Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania.
J Natl Compr Canc Netw. 2020 Mar;18(3):250-259. doi: 10.6004/jnccn.2020.7536.
Although oncology care has evolved, outcome assessment remains a key challenge. Outcome measurement requires identification and adoption of a succinct list of metrics indicative of high-quality cancer care for use within and across healthcare systems. NCCN established an advisory committee, the NCCN Quality and Outcomes Committee, consisting of provider experts from NCCN Member Institutions and other stakeholders, including payers and patient advocacy, community oncology, and health information technology representatives, to review the existing quality landscape and identify contemporary, relevant cancer quality and outcomes measures by reevaluating validated measures for endorsement and proposing new measure concepts to fill crucial gaps. This manuscript reports on 22 measures and concepts; 15 that align with existing measures and 7 that are new.
尽管肿瘤学治疗已经发展，但结果评估仍然是一个关键挑战。结果衡量需要确定并采用简明的指标列表，以表示高质量的癌症治疗，用于医疗保健系统内部和跨系统使用。NCCN 成立了一个咨询委员会，即 NCCN 质量和结果委员会，该委员会由来自 NCCN 成员机构的提供者专家和其他利益相关者组成，包括支付方和患者权益组织、社区肿瘤学和健康信息技术代表，以审查现有的质量情况，并通过重新评估已验证的措施来确定当代相关的癌症质量和结果衡量标准，为认可提出新的衡量标准概念，并提出新的概念来填补关键空白。本文报告了 22 项措施和概念；其中 15 项与现有措施一致，7 项是新的。
